Canada markets close in 1 hour 21 minutes

Akero Therapeutics, Inc. (0K4.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
17.59-1.15 (-6.13%)
As of 08:04AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
141,798
141,798
85,284
81,759
64,916
Selling General and Administrative
31,072
31,072
29,872
19,127
15,238
Total Operating Expenses
172,870
172,870
115,156
100,886
80,154
Operating Income or Loss
-172,870
-172,870
-115,156
-100,886
-80,154
Interest Expense
3,099
3,099
739
0
-
Total Other Income/Expenses Net
-
-
3,862
109
947
Income Before Tax
-151,759
-151,759
-112,033
-100,777
-79,207
Income from Continuing Operations
-151,759
-151,759
-112,033
-100,777
-79,207
Net Income
-151,759
-151,759
-112,033
-100,777
-79,207
Net Income available to common shareholders
-151,759
-151,759
-112,033
-100,777
-79,207
Basic EPS
-2.29
-2.89
-2.87
-2.89
-2.52
Diluted EPS
-2.29
-2.89
-2.87
-2.89
-2.52
Basic Average Shares
50,342
52,568
38,985
34,827
31,463
Diluted Average Shares
50,342
52,568
38,985
34,827
31,463